194 NONIGNORABLE MISSINGNESS
Similar constraints can be imposed on the parameters indexing p
1
(y
3
| y
1
,y
2
)
and p
2
(y
3
| y
1
,y
2
)tofully satisfy MAR.
Writing the model in this way makes it fairly simple to embed the MAR
specification in a large class of MNAR models indexed by parameters ∆
0
,∆
1
,
and ∆
2
that measure departures from MAR. For example, to characterize
MNAR in terms of departures from (8.27), write
α
(1)
0
= α
(≥2)
0
+∆
0
α
(1)
1
= α
(≥2)
1
+∆
1
log τ
(1)
2
=logτ
(≥2)
2
+∆
2
(8.30)
Assuming constraints(8.28) and (8.29) hold, dropout is MAR when ∆
0
=
∆
1
=∆
2
=0.Noneofthe∆parameters appears in the observed data like-
lihood. In general, a separate ∆ is needed for each model constraint, but in
practice it is necessary to limit the dimensionality of these. Our analysis of
the Growth Hormone study in Section 10.2 provides methods for doing so. 2
In Chapter 9, we formalize this structure for fully Bayesian model specifi-
cations by writing (8.30) as a function
ξ
S
= h(ξ
M
, ∆),
where ξ
S
are the (nonidentified) sensitivity parameters in the full-data model,
ξ
M
are (identified) parameters indexing the implied observed data model, and
∆ captures departures from MAR. In many cases, the h function represents
the missing data mechanism, and makes explicit howassumptions or priors
are being used to infer the full-data model (also see Rubin, 1977).
Examples 8.4 and 8.5 differ not only in how the observed data distribution is
specified, but also how the missing data are extrapolated. In Example 8.4, the
missing data distribution is identified using a mixture of normals constructed
using a weighted average of observed data distributions; see (8.26). The range
of possibilities for extrapolating missing data is confined to this structure;
though it may be fairly limited in scope, it is simple for practical settings
because of the small number of unidentified parameters (for J =3,thereis
only one).
In Example 8.5, parametric distributions are assumed for the extrapola-
tions. This imposes untestable distributional assumptions, but allows for con-
siderable flexibility in extrapolating the missing data either by fixing values
or assigning priors to parameters like (∆
0
, ∆
1
, ∆
2
)in(8.30).
Akeyconsideration for model specification, including specification of priors
or ranges for sensitivity parameters, is understanding the physical meaning of
sensitivity parameters in context. This is discussed further in Chapter 9. In
addition, in Section 10.2, we address specific related issues (model specifica-
tion, dimensionality of sensitivity parameters, formulation and interpretation
of priors, and calibration of sensitivity analyses) in a detailed analysis of data
from the growth hormone study.